Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength (Ascending) SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
31722-0131-90 31722-0131 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 7, 2016 In Use
54569-6607-00 54569-6607 Dutasteride Avodart 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Dec. 10, 2002 In Use
54868-5114-00 54868-5114 Dutasteride Avodart 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral July 16, 2004 In Use
54868-5114-01 54868-5114 Dutasteride Avodart 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral July 16, 2004 In Use
60429-0935-30 60429-0935 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Sept. 20, 2016 In Use
60429-0935-90 60429-0935 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Sept. 20, 2016 In Use
64980-0224-03 64980-0224 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 20, 2015 In Use
64980-0224-09 64980-0224 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 20, 2015 In Use
65162-0750-03 65162-0750 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 2, 2015 In Use
65162-0750-09 65162-0750 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 2, 2015 In Use
69639-0101-01 69639-0101 Netupitant and Palonosetron Akynzeo 300.0 mg/1, 0.5 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Anatagonist/Substance P/Neurokinin 1 Oral Oct. 13, 2014 In Use
69639-0101-04 69639-0101 Netupitant and Palonosetron Akynzeo 300.0 mg/1, 0.5 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Anatagonist/Substance P/Neurokinin 1 Oral Oct. 13, 2014 In Use
72865-0140-30 72865-0140 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral March 9, 2020 In Use
72865-0140-90 72865-0140 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral March 9, 2020 In Use
72578-0019-06 72578-0019 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral April 15, 2019 In Use
72578-0019-16 72578-0019 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral April 15, 2019 In Use
60432-0466-00 60432-0466 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 1983 Feb. 6, 2012 In Use
60432-0466-08 60432-0466 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 1983 In Use
54879-0003-08 54879-0003 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 21, 1976 In Use
00603-1147-56 00603-1147 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral May 11, 2011 July 31, 2017 No Longer Used
63629-2696-01 63629-2696 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 6, 2005 Nov. 11, 2021 In Use
58463-0010-08 58463-0010 dexamethasone Decadron 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral March 15, 2018 In Use
55154-3275-04 55154-3275 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 1983 July 31, 2013 No Longer Used
55154-3275-05 55154-3275 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 1983 July 31, 2013 No Longer Used
55154-3275-06 55154-3275 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 1983 July 31, 2013 No Longer Used
68850-0001-08 68850-0001 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 21, 1976 Sept. 30, 2013 No Longer Used
00054-3177-57 00054-3177 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Nov. 1, 2007 In Use
00054-3177-63 00054-3177 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 1, 1983 In Use
64679-0810-08 64679-0810 Dexamethasone Baycadron 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 1983 In Use
64980-0509-24 64980-0509 Dexamethasone Dexamethasone 0.5 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug. 1, 2011 In Use
55150-0431-01 55150-0431 DACTINOMYCIN DACTINOMYCIN 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous March 15, 2021 In Use
55150-0928-02 55150-0928 DACTINOMYCIN DACTINOMYCIN 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous March 15, 2021 In Use
67457-0513-05 67457-0513 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Jan. 1, 2018 In Use
67457-0513-99 67457-0513 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Jan. 1, 2018 In Use
67457-0928-02 67457-0928 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous June 20, 2019 In Use
55292-0811-55 55292-0811 Dactinomycin Cosmegen 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Dec. 10, 1964 Nov. 30, 2024 In Use
66993-0489-35 66993-0489 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Dec. 4, 2017 Nov. 30, 2024 In Use
00143-9167-01 00143-9167 Eribulin mesylate ERIBULIN MESYLATE 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous June 28, 2024 In Use
60505-6289-00 60505-6289 Eribulin mesylate Eribulin mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous May 6, 2024 In Use
68083-0592-01 68083-0592 Eribulin mesylate Eribulin mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous April 5, 2024 In Use
81298-3890-01 81298-3890 Eribulin Mesylate Eribulin Mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous July 22, 2024 In Use
68727-0712-01 68727-0712 Lurbinectedin ZEPZELCA 0.5 mg/mL Chemotherapy Alkylating Agent Adduct Forming Agent Intravenous June 15, 2020 In Use
62856-0389-01 62856-0389 Eribulin mesylate Halaven 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Nov. 15, 2010 In Use
39822-2100-02 39822-2100 dactinomycin dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous July 31, 2019 In Use
71288-0129-02 71288-0129 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Nov. 13, 2020 In Use
43353-0688-60 43353-0688 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jan. 1, 2006 In Use
49999-0109-00 49999-0109 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral March 21, 2012 Jan. 1, 2013 In Use
49999-0109-30 49999-0109 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral March 21, 2012 Jan. 1, 2013 In Use
49999-0109-90 49999-0109 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral March 21, 2012 June 1, 2012 In Use
53808-0770-01 53808-0770 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral July 1, 2009 In Use

Found 10,000 results in 7 milliseconds — Export these results